Intestinal metaplasia of the gastric cardia: findings in patients with versus without Barrett's esophagus

Esophagus Diseases

Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett's Esophagus after Endoscopic Therapy

Clin Gastroenterol Hepatol.

Eluri S, Earasi AG, Moist SE, Dellon ES, Shaheen NJ

doi: 10.1016/j.cgh.2019.04.065.

Helicobacter Pylori

Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication

Gut.

Sung JJY, Coker OO, Chu E, Szeto CH, Luk STY, Lau HCH, Yu J

doi: 10.1136/gutjnl-2019-319826.

Esophagus Diseases

Optimizing Management of Patients with Barrett's Esophagus and Low-grade or No Dysplasia Based On Comparative Modeling: Optimizing Barrett's esophagus management

Clin Gastroenterol Hepatol.

Omidvari AH, Ali A, Hazelton WD, Kroep S, Lee M, Naber SK, Lauren BN, Ostvar S, Richmond E, Kong CY, Rubenstein JH, Lansdorp-Vogelaar I, Luebeck G, Hur C, Inadomi J

doi: 10.1016/j.cgh.2019.11.058.

Use of Appropriate Surveillance for Patients With Non-Dysplastic Barrett's Esophagus

Clin Gastroenterol Hepatol.

Tavakkoli A, Appelman HD, Beer DG, Madiyal C, Khodadost M, Nofz K, Metko V, Elta G, Wang T, Rubenstein JH

doi: 10.1016/

Esophagus Diseases

Hybrid stomach-intestinal chromatin states underlie human Barrett's metaplasia

Gastroenterology

Singh H, Ha K, Hornick JL, Madha S, Cejas P, Jajoo K, Singh P, Polak P, Lee H, Shivdasani RA

doi: 10.1053/j.gastro.2021.05.057

Esophagus Diseases

Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus

United European Gastroenterol J.

van der Wel MJ, Klaver E, Duits LC, Pouw RE, Seldenrijk CA, Offerhaus G, Visser M, Ten Kate F, Biermann K, Brosens L, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan JS, van Lijnschoten G, Moll F, Ooms A, Tijssen JG, Bergman J, Meijer SL

doi: 10.1177/2050640619853441.

Esophagus Diseases

Biomarkers for Barrett's esophagus - a contemporary review

Expert Rev Mol Diagn.

Qureshi AP, Stachler MD, Haque O, Odze RD

doi: 10.1080/14737159.

Esophagus Diseases

Estimating neoplasia detection rate (NDR) in patients with Barrett's oesophagus based on index endoscopy: a systematic review and meta-analysis

Gut.

Parasa S, Desai M, Vittal A, Chandrasekar VT, Pervez A, Kennedy KF, Gupta N, Shaheen NJ, Sharma P

doi: 10.1136/gutjnl-2018-317800.

Esophagus Diseases

Cryotherapy for persistent Barrett's esophagus after radiofrequency ablation: a systematic review and meta-analysis

Gastrointest Endosc.

Visrodia K, Zakko L, Singh S, Leggett CL, Iyer PG, Wang KK

doi: 10.1016/j.gie.2018.02.021.

Related content

Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett's Esophagus after Endoscopic Therapy

Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication

Optimizing Management of Patients with Barrett's Esophagus and Low-grade or No Dysplasia Based On Comparative Modeling: Optimizing Barrett's esophagus management

Use of Appropriate Surveillance for Patients With Non-Dysplastic Barrett's Esophagus

Hybrid stomach-intestinal chromatin states underlie human Barrett's metaplasia

Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus

Biomarkers for Barrett's esophagus - a contemporary review

Estimating neoplasia detection rate (NDR) in patients with Barrett's oesophagus based on index endoscopy: a systematic review and meta-analysis

Cryotherapy for persistent Barrett's esophagus after radiofrequency ablation: a systematic review and meta-analysis